Skip to content
← Back to this collection

PUBLICATIONS · 17420513

Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2007 May 20
First author
Herold M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Herold M
      type
      Author
    2. name
      Haas A
      type
      Author
    3. name
      Srock S
      type
      Author
    4. name
      Neser S
      type
      Author
    5. name
      Al-Ali KH
      type
      Author
    6. name
      Neubauer A
      type
      Author
    7. name
      Dölken G
      type
      Author
    8. name
      Naumann R
      type
      Author
    9. name
      Knauf W
      type
      Author
    10. name
      Freund M
      type
      Author
    11. name
      Rohrberg R
      type
      Author
    12. name
      Höffken K
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Herold M
      type
      Author
    2. name
      Haas A
      type
      Author
    3. name
      Srock S
      type
      Author
    4. name
      Neser S
      type
      Author
    5. name
      Al-Ali KH
      type
      Author
    6. name
      Neubauer A
      type
      Author
    7. name
      Dölken G
      type
      Author
    8. name
      Naumann R
      type
      Author
    9. name
      Knauf W
      type
      Author
    10. name
      Freund M
      type
      Author
    11. name
      Rohrberg R
      type
      Author
    12. name
      Höffken K
      type
      Author
    bibliography ids
    1. nci-bib-c07f91cd3cc5fd86f2175db4
    book metadata
    content sha256
    a6f843266dd5e5da189aa41711969fed43b4f02faeab947c6ada6f2c4e03dacd
    document type
    citation
    dois
    1. 10.1200/JCO.2006.06.4618
    electronic publication date
    display
    2007 Apr 9
    precision
    day
    year
    2007
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:17420513
    immutable id
    pubmed:17420513@a6f843266dd5e5da189aa41711969fed43b4f02faeab947c6ada6f2c4e03dacd
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    15
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1986-92
    volume
    25
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      17420513
      provenance
      batch id
      e687ecc838c318f9ec65
      provider
      NCBI PubMed ESummary
      record sha256
      1a0da90b96843e6a261aab3130812819d83df145e3f7764170ad07db1b0db67d
      response sha256
      57c28819ed5384f58bd55b57a106357c87d58ddac21f26fe526ca7520d9f61c6
      retrieved at
      2026-09-09T23:46:11.674833+00:00
      publication date
      display
      2007 May 20
      precision
      day
      year
      2007
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/17420513/
      title
      Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study.

      Preserved source evidence · Independent clinical review pending · Not medical advice